Lazard Asset Management LLC Wave Life Sciences Ltd. Transaction History
Lazard Asset Management LLC
- $68.3 Billion
- Q3 2024
A detailed history of Lazard Asset Management LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Lazard Asset Management LLC holds 217 shares of WVE stock, worth $2,966. This represents 0.0% of its overall portfolio holdings.
Number of Shares
217
Previous 447
51.45%
Holding current value
$2,966
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$249 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$137 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$133 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$92.1 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$84.3 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.19B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...